TYRUOS FINANCE
Opening research…
Retrieving research data…
Workspace/Market
TYRUOS FINANCE
8.75NOK
+0.12 (+1.39%)
Sandbox quote · 11 Sept, 14:30 UTC
Daily closing prices returned by the sandbox.
| Date | Close | Volume |
|---|---|---|
| 10 Sept 2026 | 8.90 | 2,277,238 |
| 8 Sept 2026 | 8.90 | 2,277,238 |
| 7 Sept 2026 | 8.30 | 18,751,032 |
| 6 Sept 2026 | 1.10 | 2,292,447 |
| 5 Sept 2026 | 1.15 | 4,162,662 |
| 4 Sept 2026 | 1.06 | 1,198,593 |
| 3 Sept 2026 | 1.06 | 1,569,425 |
| 2 Sept 2026 | 1.05 | 2,205,399 |
| 30 Aug 2026 | 1.01 | 2,372,920 |
| 29 Aug 2026 | 1.05 | 2,754,027 |
| 28 Aug 2026 | 1.08 | 1,408,147 |
| 27 Aug 2026 | 1.07 | 2,136,922 |
| 26 Aug 2026 | 1.14 | 4,358,140 |
| 23 Aug 2026 | 1.23 | 3,195,393 |
| 22 Aug 2026 | 1.27 | 3,166,014 |
| 21 Aug 2026 | 1.22 | 948,070 |
| 20 Aug 2026 | 1.23 | 1,402,565 |
| 19 Aug 2026 | 1.21 | 1,172,934 |
| 16 Aug 2026 | 1.22 | 3,356,621 |
| 13 Aug 2026 | 1.16 | 572,965 |
| 12 Aug 2026 | 1.18 | 1,571,870 |
| 6 Aug 2026 | 1.18 | 933,582 |
| 5 Aug 2026 | 1.17 | 1,992,218 |
| 2 Aug 2026 | 1.21 | 1,486,598 |
| 1 Aug 2026 | 1.18 | 2,194,906 |
| 31 Jul 2026 | 1.23 | 2,727,588 |
| 30 Jul 2026 | 1.19 | 4,312,267 |
| 29 Jul 2026 | 1.26 | 3,049,740 |
| 26 Jul 2026 | 1.28 | 5,896,643 |
| 25 Jul 2026 | 1.39 | 10,623,801 |
| 24 Jul 2026 | 1.44 | 10,910,756 |
| 23 Jul 2026 | 1.14 | 7,574,382 |
| 22 Jul 2026 | 1.20 | 13,847,804 |
| 19 Jul 2026 | 1.26 | 5,650,079 |
| 18 Jul 2026 | 1.40 | 5,278,335 |
| 17 Jul 2026 | 1.40 | 14,239,268 |
| 16 Jul 2026 | 1.22 | 5,454,880 |
| 15 Jul 2026 | 1.07 | 1,331,481 |
| 12 Jul 2026 | 1.06 | 2,969,507 |
| 11 Jul 2026 | 1.10 | 2,759,039 |
| 10 Jul 2026 | 1.04 | 4,764,435 |
Sandbox observations are not verified live market data.
Historical adjustments are unverified: the sandbox returned inconsistent series for adjustment options.
Sandbox source dates can reflect replayed data and conflict with modification or original document dates.
Circio Holding is a pharmaceutical company. The company's specialist expertise is found in targeted immunotherapy used in the treatment of cancer patients. The company's operations consist of research and development and the medicines are sold under separate brands. Several partnerships in the market have been entered into to strengthen cooperation in the development of new immunotherapy. The company was founded in 2010 and is headquartered in Lysaker.
Millistream MWS sandbox · Retrieved 11 Sept, 19:39 UTC
Market capitalisation
2.4bnNOK
Sandbox quote snapshot
Day volume
5.49m
Reported traded quantity
Day range
8.60–9.05
NOK · Low to high
Previous close
8.63NOK
Provider-reported reference
What the returned data says, and what it cannot tell you. Sandbox data; every card links to its evidence.
What moved
+1.39%
Last 8.75 NOK · previous close 8.63
Volume 5.49m · market cap 2.4bn
Nordnet Bank AB
4.90% of capital · 4.90% of votes
Top 5 returned holders: 18.50% of capital
Regulatory announcement
Circio Holding ASA – Updated key information relating to the rights issue
Data coverage